Hemostemix(DE:2VF0)
€0.020.00 (-9.09%)
DE:2VF0
Hemostemix financials statements
€0.02
At close:0.00 (-9.09%)
Hemostemix (2VF0) Ratios
0 Followers
Hemostemix Ratios
DE:2VF0's free cash flow for Q2 2026 was C$-380.93K. For the 2026 fiscal year, DE:2VF0's free cash flow was increased by C$0.00 and operating cash flow was C$-380.93K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.49 | 0.36 | 0.11 | 0.18 | 0.13 |
| Quick Ratio | 0.49 | 0.36 | 0.11 | 0.18 | 0.13 |
| Cash Ratio | 0.39 | 0.25 | 0.05 | 0.05 | 0.05 |
| Solvency Ratio | -0.81 | -0.32 | -0.33 | -0.72 | -1.07 |
| Operating Cash Flow Ratio | -2.62 | -0.69 | -0.49 | -2.33 | -0.80 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | C$ -4.97M | C$ -7.20M | C$ -7.37M | C$ -6.77M | C$ -5.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.25 | 4.98 | 13.77 | 8.87 | 2.63 |
| Debt-to-Equity Ratio | -0.72 | -0.69 | -0.59 | -0.61 | -0.28 |
| Debt-to-Capital Ratio | -2.63 | -2.18 | -1.42 | -1.56 | -0.39 |
| Long-Term Debt-to-Capital Ratio | -2.63 | -2.18 | -1.42 | -1.56 | -0.39 |
| Financial Leverage Ratio | -0.17 | -0.14 | -0.04 | -0.07 | -0.11 |
| Debt Service Coverage Ratio | -7.61 | -3.17 | -3.50 | -13.79 | -590.25 |
| Interest Coverage Ratio | -10.05 | -3.17 | -3.88 | -12.93 | -635.64 |
| Debt to Market Cap | 0.24 | 0.43 | 0.75 | 0.33 | 0.16 |
| Interest Debt Per Share | 0.03 | 0.06 | 0.06 | 0.06 | 0.03 |
| Net Debt to EBITDA | -0.69 | -2.14 | -2.14 | -0.91 | -0.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 110.23% | 96.09% |
| EBT Per EBIT | 83.69% | 132.19% | 116.00% | 103.74% | 98.14% |
| Return on Assets (ROA) | -556.61% | -263.75% | -797.41% | -1124.97% | -1116.43% |
| Return on Equity (ROE) | 94.80% | 36.31% | 33.94% | 77.34% | 118.97% |
| Return on Capital Employed (ROCE) | 637.89% | 111.15% | 84.16% | 212.34% | 175.33% |
| Return on Invested Capital (ROIC) | 637.89% | 111.15% | 84.16% | 212.34% | 168.47% |
| Return on Tangible Assets | -556.61% | -263.75% | -797.41% | -1124.97% | -1116.43% |
| Earnings Yield | -32.05% | -22.93% | -43.32% | -41.56% | -68.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.21 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -13726761.30 | -10119176.05 | -4708283.95 | -1767.48 | -1447082.45 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 13726761.30 | 10119176.05 | 4708283.95 | 1767.48 | 1447082.45 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.02 | -0.02 | -0.09 | -0.06 |
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.02 | -0.09 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -354940.25 | -1525436.25 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -354940.25 | -1525436.25 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.26 | -0.39 | -0.33 | -1.48 | -2.35 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -30.83% | -16.68% | -24.58% | -48.44% | -37.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.13 | -4.36 | -2.31 | -2.41 | -1.46 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -2.96 | -1.58 | -0.78 | -1.86 | -1.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.24 | -6.00 | -4.07 | -2.06 | -2.64 |
| Price-to-Operating Cash Flow Ratio | -3.24 | -6.00 | -4.07 | -2.06 | -2.64 |
| Price-to-Earnings Growth (PEG) Ratio | -0.66 | 0.47 | 0.04 | 0.08 | 0.03 |
| Enterprise Value Multiple | -4.14 | -7.90 | -5.11 | -3.77 | -1.62 |
| Enterprise Value | 17.63M | 15.64M | 9.94M | 16.59M | 10.45M |
| EV to EBITDA | -4.14 | -7.90 | -5.11 | -3.77 | -1.62 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.89 | -8.22 | -7.00 | -2.72 | -3.01 |
| EV to Operating Cash Flow | -3.89 | -8.22 | -7.00 | -2.72 | -3.01 |
| Tangible Book Value Per Share | -0.03 | -0.08 | -0.09 | -0.10 | -0.09 |
| Shareholders’ Equity Per Share | -0.03 | -0.08 | -0.09 | -0.10 | -0.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.10 | 0.04 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.03 | -0.03 | -0.03 | -0.07 | -0.11 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.10 | 0.96 |
| Interest Burden | 1.11 | 1.32 | 1.29 | 1.08 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.96 | 0.73 | 0.57 | 1.17 | 0.55 |
Currency in CAD
